Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2

Molecular Cancer Therapeutics
Carolyn CaoBo Lu

Abstract

p53 plays a critical role in cell cycle arrest and induction of apoptosis. Certain malignancies carry wild-type p53, which is frequently down-regulated by murine double minute 2 (MDM2) overexpression. Availability of a small-molecule inhibitor against MDM2, nutlin, has made it feasible to evaluate the anti-MDM2-based therapeutic strategies. The rationale for the current study is that functional p53 has been linked with improved responses to radiation treatment. Hence, this study evaluates the use of nutlin, a small-molecule inhibitor that blocks the interaction of p53 and MDM2, in sensitizing cancer cells to radiation. Expression of MDM2, p53, and p21 in both p53 wild-type and p53-defective lung cancer cell lines was examined. Clonogenic and 7-amino-actinomycin D studies were used to determine possible mechanisms of cell death. The combined effect of MDM2 inhibition and radiation on cell cycle was also studied. We found that radiosensitization by nutlin occurs in lung cancer cells with wild-type p53. There were increased apoptosis and cell cycle arrest following administration of nutlin and radiation. Furthermore, the combination of nutlin and radiation decreased the ability of endothelial cells to form vasculature, as shown by...Continue Reading

References

Jul 1, 1993·Genes & Development·X WuA J Levine
Aug 12, 2005·Molecular Cancer Therapeutics·Carolyn CaoBo Lu

❮ Previous
Next ❯

Citations

Mar 5, 2009·Apoptosis : an International Journal on Programmed Cell Death·Chao Lu, Wafik S El-Deiry
Oct 16, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Venkata Reddy Bandugula, Rajendra Prasad N
Feb 9, 2010·Oncogene·S LamA G Jochemsen
Jun 10, 2006·Cell Death and Differentiation·K B SpurgersT J McDonnell
Nov 30, 2006·The Journal of Biological Chemistry·Man JiangZheng Dong
Nov 12, 2009·Journal of the National Cancer Institute·Tom Van MaerkenJo Vandesompele
Nov 30, 2006·Current Opinion in Oncology·Alex Gaither, Vadim Iourgenko
Nov 16, 2010·Molecular Cancer Therapeutics·Hongbo WangChunhong Yan
Apr 1, 2008·Biomarkers in Medicine·Andrea L RussoKevin Camphausen
Mar 1, 2014·Nature Reviews. Drug Discovery·Kian Hoe KhooDavid P Lane
May 22, 2009·Expert Opinion on Therapeutic Patents·Francis DumontPierre Bischoff
Feb 16, 2012·Biochimica Et Biophysica Acta·Kelly D SullivanJoaquín M Espinosa
Feb 19, 2010·Translational Oncology·Zhen Wang, Yi Sun
Jun 21, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C ChargariE Deutsch
Jan 18, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C ChargariE Deutsch
Mar 3, 2010·Seminars in Cancer Biology·Anwesha DeyChandra S Verma
Apr 22, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hsi-Feng TuKuo-Wei Chang
Sep 21, 2007·Journal of Cellular Biochemistry·Xiao-Chun ZhangMong-Hong Lee
Sep 11, 2012·International Journal of Cancer. Journal International Du Cancer·Roser MirPepita Giménez-Bonafé
Oct 26, 2016·Advances in Biological Regulation·James A McCubreyLinda S Steelman
Jul 31, 2012·Acta Biochimica Et Biophysica Sinica·Bo WangDechun Wang
May 9, 2018·Journal of Cancer Research and Clinical Oncology·Uljana A BoyarskikhMaxim L Filipenko
Oct 27, 2010·Nature Reviews. Clinical Oncology·Chit Fang CheokDavid P Lane
Nov 27, 2016·Oncotarget·Karin HientzThomas Efferth
Jul 30, 2020·Scientific Reports·Beata HatTomasz Lipniacki
Aug 28, 2019·Journal of Cellular Biochemistry·Babak BajelanFarzad Rajaei
Jul 3, 2008·Cancer Research·Helen S Bell, Kevin M Ryan
Sep 21, 2006·Molecular Cancer Therapeutics·Eveline BarbieriJason M Shohet
Apr 17, 2008·Molecular Cancer Therapeutics·Stéphane SupiotRobert G Bristow
Jun 24, 2009·Chemical Reviews·Mats Ljungman
Oct 11, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Tiffany G ChanBart Cornelissen
Jul 27, 2021·Frontiers in Oncology·Xanthene MilesJulie Bolcaen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis